Phase III study on efficacy of taxanes plus bevacizumab with or without capecitabine as first-line chemotherapy in metastatic breast cancer

Lueck, Hans-Joachim; Luebbe, Kristina; Reinisch, Mattea; Maass, Nicolai; Feisel-Schwickardi, Gabriele; Tome, Oliver; Janni, Wolfgang; Aydogdu, Mustafa; Neunhoeffer, Tanja; Ober, Angelika; Aktas, Bahriye; Park-Simon, Tjoung-Won; Schumacher, Claudia; Hoeffkes, Heinz-Gert; Illmer, Thomas; Wagner, Harald; Mehta, Keyur; von Minckwitz, Gunter; Nekljudova, Valentina; Loibl, Sibylle

Erstveröffentlichung

2015

Metadata only
Search for full text

Wissenschaftlicher Artikel

Authors

Lueck, Hans-Joachim

Luebbe, Kristina

Reinisch, Mattea

Maass, Nicolai

Feisel-Schwickardi, Gabriele

et al.

Institutions

UKU. Klinik für Frauenheilkunde und Geburtshilfe

Published in

Breast cancer research and treatment ; 149 (2015), 1. - S. 141-149. - ISSN 0167-6806. - eISSN 1573-7217

Link to publication

https://dx.doi.org/10.1007/s10549-014-3217-y

Keywords

Metastatic breast cancer; Capecitabine; Bevacizumab; Taxane; Response; Progression-free survival; COMBINATION THERAPY; PACLITAXEL; TRIAL; SURVIVAL; DOCETAXEL; SAFETY

Dewey Decimal Group

DDC 610 / Medicine & health

Metadata

Show full item record